chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Lymphadenopathy, Vaccination site pain
Clinical narrative: lymph node is big enough ( noticeable; clavicle gland is big; Vaccination site pain; flushing red face; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), FLUSHING (flushing red face), LYMPHADENOPATHY (lymph node is big enough ( noticeable) and LYMPHADENOPATHY (clavicle gland is big) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain) and FLUSHING (flushing red face). On an unknown date, the patient experienced LYMPHADENOPATHY (lymph node is big enough ( noticeable) and LYMPHADENOPATHY (clavicle gland is big). On 03-Apr-2021, FLUSHING (flushing red face) had resolved. At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) had resolved and LYMPHADENOPATHY (lymph node is big enough ( noticeable) and LYMPHADENOPATHY (clavicle gland is big) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided    Reporter did not allow further contact
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L22A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills). On 31-Jan-2021, CHILLS (Chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided by the reporter. No concomitant medication was provided by the reporter. No lab data was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-081369 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081369:Second dose case
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: glands under her left arm are "quite miserable"; fever; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (glands under her left arm are "quite miserable") and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (glands under her left arm are "quite miserable") and PYREXIA (fever). At the time of the report, LYMPHADENOPATHY (glands under her left arm are "quite miserable") and PYREXIA (fever) outcome was unknown.            Concomitant medication was not provided Treatment information was not provided   This case was linked to MOD-2021-081357 (Linked Report). This case was linked to MOD-2021-081344 (Patient Link).; Sender's Comments:  MOD-2021-081357:Dose-2
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash looks like little red dots; Rash at the injection site; Itching at the injection; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Rash looks like little red dots), VACCINATION SITE PRURITUS (Itching at the injection) and VACCINATION SITE RASH (Rash at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood cholesterol abnormal (Statin for cholesterol) and Blood pressure abnormal (Blood pressure pills). Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for Cholesterol, METOPROLOL, WARFARIN and VITAMIN D NOS for an unknown indication.    On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection). On 20-Apr-2021, the patient experienced RASH MACULAR (Rash looks like little red dots) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, RASH MACULAR (Rash looks like little red dots), VACCINATION SITE PRURITUS (Itching at the injection) and VACCINATION SITE RASH (Rash at the injection site) was resolving.            No Treatment was provided by Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up received on 21-May-2021:event outcome (unknown to recovering) was updated.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission in error, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of SARS-CoV-2 test (tested positive for COVID-19) and product dose omission in error (second dose missed greater than day 36) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 012A21A) for COVID-19 immunization. Concurrent medical conditions included obesity. On Mar 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 25, 2021, patient had a positive SARS-CoV-2 test (tested positive for COVID-19). On an unknown date, patient experienced product dose omission in error (second dose missed greater than day 36). The patient treated with Bamlanivimab Mar 25, 2021 for COVID-19, at an unspecified dose and frequency. At the time of the report, SARS-CoV-2 test (tested positive for COVID-19) and product dose omission in error (second dose missed greater than day 36) outcome: unknown. Diagnostic results: On Mar 25, 2021, SARS-CoV-2 test: Positive. Tested positive for COVID-19. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Fatigue, Illness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BREAST TENDERNESS (Horrible breast tenderness, really bad), ILLNESS (Sick) and FATIGUE (Fatigue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced BREAST TENDERNESS (Horrible breast tenderness, really bad), ILLNESS (Sick) and FATIGUE (Fatigue). At the time of the report, BREAST TENDERNESS (Horrible breast tenderness, really bad), ILLNESS (Sick) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up information received on 21-May-2021 contains non-significant information.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Feeling hot, Nasal congestion, Rash, Throat irritation
Clinical narrative: Blister really hot; scratchy throat; really hot; Congestion; Back rash; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion) and RASH (Back rash) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Blister really hot; scratchy throat; really hot; Congestion; Back rash; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion) and RASH (Back rash) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, BLISTER (Blister really hot), THROAT IRRITATION (scratchy throat), FEELING HOT (really hot), NASAL CONGESTION (Congestion), RASH (Back rash) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling, Urticaria, Vaccination site urticaria
Clinical narrative: Itching; Whelps in front and back torso; Swollen places (some as big as Silver Dollars); Whelps down right arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), URTICARIA (Whelps in front and back torso), SWELLING (Swollen places (some as big as Silver Dollars)) and VACCINATION SITE URTICARIA (Whelps down right arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRURITUS (Itching), URTICARIA (Whelps in front and back torso), SWELLING (Swollen places (some as big as Silver Dollars)) and VACCINATION SITE URTICARIA (Whelps down right arm). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. On 03-Apr-2021, PRURITUS (Itching), URTICARIA (Whelps in front and back torso), SWELLING (Swollen places (some as big as Silver Dollars)) and VACCINATION SITE URTICARIA (Whelps down right arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Formication, Headache, Off label use
Clinical narrative: dose 1 was administered 62 days ago without a second dose administered yet; creepy crawly sensation on the face; face ache; nagging "low grade" headache; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (dose 1 was administered 62 days ago without a second dose administered yet), FORMICATION (creepy crawly sensation on the face), FACIAL PAIN (face ache) and HEADACHE (nagging "low grade" headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEADACHE (nagging "low grade" headache). On 24-Feb-2021, the patient experienced FORMICATION (creepy crawly sensation on the face) and FACIAL PAIN (face ache). On 20-Apr-2021, the patient experienced OFF LABEL USE (dose 1 was administered 62 days ago without a second dose administered yet). On 10-Mar-2021, FORMICATION (creepy crawly sensation on the face), FACIAL PAIN (face ache) and HEADACHE (nagging "low grade" headache) had resolved. At the time of the report, OFF LABEL USE (dose 1 was administered 62 days ago without a second dose administered yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  Treatment medication included Advil.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling hot, Vomiting
Clinical narrative: felt heated; uncomfortable; vomiting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting). At the time of the report, FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   19-Apr-2021 The nurse practitioner at the clinic was on speaker phone with the patient and stated patient's skin was "warm and dry and the patient is feeling better now."  No concomitant medications were reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Nausea, Neck pain, Pyrexia
Clinical narrative: lingering neck pain; lethargy; fever; chills; nausea; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (lingering neck pain), LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NECK PAIN (lingering neck pain). 06-Mar-2021, the patient experienced LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (MORTIN) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 10-Mar-2021, LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) had resolved. At the time of the report, NECK PAIN (lingering neck pain) outcome was unknown.            No concomitant medications were reported.   .   This case was linked to US-MODERNATX, INC.-MOD-2021-081356 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081356:1ST DOSE
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Sinusitis
Clinical narrative: Positive for COVID19 virus after 1st Moderna Vaccination; Felt like a sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive for COVID19 virus after 1st Moderna Vaccination) and SINUSITIS (Felt like a sinus infection) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Dec-2020, the patient experienced COVID-19 (Positive for COVID19 virus after 1st Moderna Vaccination) and SINUSITIS (Felt like a sinus infection). At the time of the report, COVID-19 (Positive for COVID19 virus after 1st Moderna Vaccination) and SINUSITIS (Felt like a sinus infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash macular, Vaccination site pain, Vaccination site reaction
Clinical narrative: knot under the skin around the site of injection which is hot to touch; started to hurt again; redness and splotchiness on his arm below his elbow; Redness; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), RASH MACULAR (redness and splotchiness on his arm below his elbow), VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch), VACCINATION SITE PAIN (arm soreness) and VACCINATION SITE PAIN (started to hurt again) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced ERYTHEMA (Redness) and VACCINATION SITE PAIN (arm soreness). On 14-Apr-2021, the patient experienced RASH MACULAR (redness and splotchiness on his arm below his elbow). On 20-Apr-2021, the patient experienced VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch) and VACCINATION SITE PAIN (started to hurt again). The patient was treated with IBUPROFEN for Pain in arm, at an unspecified dose and frequency. On 15-Apr-2021, RASH MACULAR (redness and splotchiness on his arm below his elbow) had resolved. On 16-Apr-2021, ERYTHEMA (Redness) and VACCINATION SITE PAIN (arm soreness) had resolved. At the time of the report, VACCINATION SITE REACTION (knot under the skin around the site of injection which is hot to touch) and VACCINATION SITE PAIN (started to hurt again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Headache, Malaise, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts) and DISCOMFORT (her body feels heavy) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts), DISCOMFORT (her body feels heavy) and FATIGUE (feels tired.). At the time of the report, MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts), DISCOMFORT (her body feels heavy) and FATIGUE (feels tired.) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts) and DISCOMFORT (her body feels heavy) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts), DISCOMFORT (her body feels heavy) and FATIGUE (feels tired.). At the time of the report, MALAISE (feels under the weather), PAIN (achy), HEADACHE (headache), PAIN IN EXTREMITY (her arm hurts), DISCOMFORT (her body feels heavy) and FATIGUE (feels tired.) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue
Clinical narrative: Lower back pain; Fatigue; This spontaneous case was reported by an other caregiver and describes the occurrence of BACK PAIN (Lower back pain) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced FATIGUE (Fatigue). On 19-Apr-2021, the patient experienced BACK PAIN (Lower back pain). At the time of the report, BACK PAIN (Lower back pain) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medications were not reported Treatment received in response to the events was not reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. This spontaneous case was reported by an other caregiver and describes the occurrence of LOW BACK PAIN (Lower back pain) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  On 19-Apr-2021, the patient experienced LOW BACK PAIN (Lower back pain). At the time of the report, LOW  BACK PAIN (Lower back pain) and FATIGUE (Fatigue) outcome was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fatigue; Really low grade fever between 99.1-99.7; body aches; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), PYREXIA (Really low grade fever between 99.1-99.7), MYALGIA (body aches), PYREXIA (Fever) and HEADACHE (Headache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced MYALGIA (body aches), PYREXIA (Fever) and HEADACHE (Headache). On 19-Apr-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (Really low grade fever between 99.1-99.7). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 18-Apr-2021, MYALGIA (body aches), PYREXIA (Fever) and HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (Fatigue) and PYREXIA (Really low grade fever between 99.1-99.7) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Body temperature: 99.1-99.7 (High) Low grade fever.         No relevant concomitant medications were reported.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Rash, Rash pruritic
Clinical narrative: itchy rash; little red bumps; rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash); in the legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs). The patient was treated with CETIRIZINE HYDROCHLORIDE (ALLERCET) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (itchy rash), INJECTION SITE MASS (little red bumps), RASH (rash appeared first in the forearm and the expanded to the whole arm (but it was a lighter rash)) and RASH (in the legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Chills, Diarrhoea, Dizziness, Fatigue
Clinical narrative: Dizzy; She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better; Severe Side Effects; Diarrhea; Urge to go to the bathroom 6-7 times a day but nothing (#2) came out; Nausea; Vomiting; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea) and DIZZINESS (Dizzy) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and FATIGUE (Fatigue). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better) and DIZZINESS (Dizzy). On 19-Mar-2021, POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pollakiuria, Product dose omission issue, Vomiting
Clinical narrative: Dizzy; She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better; Severe Side Effects; Diarrhea; Urge to go to the bathroom 6-7 times a day but nothing (#2) came out; Nausea; Vomiting; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea) and DIZZINESS (Dizzy) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and FATIGUE (Fatigue). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better) and DIZZINESS (Dizzy). On 19-Mar-2021, POLLAKIURIA (Urge to go to the bathroom 6-7 times a day but nothing (#2) came out), ADVERSE REACTION (Severe Side Effects), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (She was scheduled to receive the second dose on 08APR2021 but MD told her to wait until she feels better), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: sore arm; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NAUSEA (nausea) and PYREXIA (fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NAUSEA (nausea) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea) outcome was unknown.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Headache, Insomnia
Clinical narrative: trouble breathing; cough; sore; body aches; headache; No energy; lethargic; trouble sleeping at night; swelling on left arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing), ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night) and COUGH (cough) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient reports he had COVID before - diagnosed March 17, 2020.) on 17-Mar-2020.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling on left arm). On 18-Apr-2021, the patient experienced ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night), PAIN (sore), MYALGIA (body aches) and HEADACHE (headache). On 19-Apr-2021, the patient experienced DYSPNOEA (trouble breathing) and COUGH (cough). At the time of the report, DYSPNOEA (trouble breathing), ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night), COUGH (cough), PAIN (sore), PERIPHERAL SWELLING (swelling on left arm), MYALGIA (body aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs provided.  Treatment for the events included albuterol, Tylenol, and Nyquil.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Pain, Peripheral swelling
Clinical narrative: trouble breathing; cough; sore; body aches; headache; No energy; lethargic; trouble sleeping at night; swelling on left arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing), ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night) and COUGH (cough) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient reports he had COVID before - diagnosed March 17, 2020.) on 17-Mar-2020.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling on left arm). On 18-Apr-2021, the patient experienced ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night), PAIN (sore), MYALGIA (body aches) and HEADACHE (headache). On 19-Apr-2021, the patient experienced DYSPNOEA (trouble breathing) and COUGH (cough). At the time of the report, DYSPNOEA (trouble breathing), ASTHENIA (No energy), LETHARGY (lethargic), INSOMNIA (trouble sleeping at night), COUGH (cough), PAIN (sore), PERIPHERAL SWELLING (swelling on left arm), MYALGIA (body aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs provided.  Treatment for the events included albuterol, Tylenol, and Nyquil.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Palmar-plantar erythrodysaesthesia syndrome, Peripheral swelling, Pharyngeal swelling, Pruritus
Clinical narrative: generalized itchiness; mild throat swelling; Fingers are swollen; feet are swollen; Subjective itchiness in hands and feet; hand swelling; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen) and PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Goiter. Concomitant products included ALBUTEROL SULFATE for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen), PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) and PERIPHERAL SWELLING (hand swelling). At the time of the report, PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen), PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) and PERIPHERAL SWELLING (hand swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: generalized itchiness; mild throat swelling; Fingers are swollen; feet are swollen; Subjective itchiness in hands and feet; hand swelling; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen) and PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Goiter. Concomitant products included ALBUTEROL SULFATE for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen), PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) and PERIPHERAL SWELLING (hand swelling). At the time of the report, PRURITUS (generalized itchiness), PHARYNGEAL SWELLING (mild throat swelling), VACCINATION SITE SWELLING (Fingers are swollen), JOINT SWELLING (feet are swollen), PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (Subjective itchiness in hands and feet) and PERIPHERAL SWELLING (hand swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose not administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not administered). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not administered) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Vaccination complication
Clinical narrative: AE she had to the first dose; Her PCP told her to not take the second shot due to the AE she had to the first dose; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Her PCP told her to not take the second shot due to the AE she had to the first dose) and VACCINATION COMPLICATION (AE she had to the first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced OFF LABEL USE (Her PCP told her to not take the second shot due to the AE she had to the first dose). On an unknown date, the patient experienced VACCINATION COMPLICATION (AE she had to the first dose). On 21-Jan-2021, OFF LABEL USE (Her PCP told her to not take the second shot due to the AE she had to the first dose) had resolved. At the time of the report, VACCINATION COMPLICATION (AE she had to the first dose) outcome was unknown.            Concomitant medications were not reported. No treatment details were reported. Patient could not receive the second shot as it was canceled.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Headache, Nausea
Clinical narrative: fatigued; slept for pretty much 13 hours, maybe more than that; slight headache; Nausea; fatigued; slept for pretty much 13 hours, maybe more than that; chills; feels like he's burning up but don't have a fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, and CHILLS in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT. At the time of the report, SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included Tylenol.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: fatigued; slept for pretty much 13 hours, maybe more than that; slight headache; Nausea; fatigued; slept for pretty much 13 hours, maybe more than that; chills; feels like he's burning up but don't have a fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, and CHILLS in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT. At the time of the report, SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included Tylenol.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Fatigue, Impaired work ability
Clinical narrative: cannot eat anything; Can not go to work; diarrhea; Rash on the arm at the injection site; fatigue; muscle pain; chills; Rash is swollen on the arm at the injection site; Rash is red on the arm at the injection site; Rash is itchy on the arm at the injection site; Rash is painful on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site) and VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site) and VACCINATION SITE RASH (Rash on the arm at the injection site). On 17-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and IMPAIRED WORK ABILITY (Can not go to work). On an unknown date, the patient experienced DECREASED APPETITE (cannot eat anything). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site), DIARRHOEA (diarrhea), DECREASED APPETITE (cannot eat anything), IMPAIRED WORK ABILITY (Can not go to work) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product usage were not provided. Treatment details were not provided.